Consonance Capital Management as of June 30, 2019
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 30 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amarin Corp Spons Adr New (AMRN) | 11.8 | $167M | 8.6M | 19.39 | |
Uniqure Nv SHS (QURE) | 10.6 | $149M | 1.9M | 78.15 | |
Iovance Biotherapeutics (IOVA) | 10.2 | $144M | 5.9M | 24.52 | |
Pacira Pharmaceuticals (PCRX) | 8.6 | $122M | 2.8M | 43.49 | |
Retrophin | 5.4 | $77M | 3.8M | 20.09 | |
Catalyst Pharmaceutical Partners (CPRX) | 4.9 | $69M | 18M | 3.84 | |
United Therapeutics Corporation (UTHR) | 4.3 | $60M | 771k | 78.06 | |
Epizyme | 4.2 | $60M | 4.8M | 12.55 | |
Vericel (VCEL) | 3.9 | $55M | 2.9M | 18.89 | |
Urogen Pharma (URGN) | 3.6 | $52M | 1.4M | 35.94 | |
Vanda Pharmaceuticals (VNDA) | 3.6 | $51M | 3.6M | 14.09 | |
Omeros Corporation (OMER) | 3.4 | $48M | 3.1M | 15.69 | |
Aerie Pharmaceuticals | 3.2 | $45M | 1.5M | 29.55 | |
Insmed Com Par $.01 (INSM) | 3.1 | $44M | 1.7M | 25.60 | |
Karyopharm Therapeutics (KPTI) | 2.5 | $35M | 5.8M | 5.99 | |
Oxford Immunotec Global Ord Shs | 2.3 | $32M | 2.3M | 13.76 | |
Corcept Therapeutics Incorporated (CORT) | 2.3 | $32M | 2.9M | 11.15 | |
Intercept Pharmaceuticals In | 2.2 | $31M | 389k | 79.57 | |
Aurinia Pharmaceuticals (AUPH) | 2.0 | $28M | 4.2M | 6.58 | |
Kadmon Hldgs | 1.7 | $24M | 12M | 2.06 | |
Adma Biologics (ADMA) | 1.6 | $22M | 5.7M | 3.87 | |
Chemocentryx | 1.1 | $16M | 1.7M | 9.30 | |
Staar Surgical Com Par $0.01 (STAA) | 1.0 | $14M | 485k | 29.38 | |
Mustang Bio | 0.9 | $12M | 3.4M | 3.68 | |
Biosante Pharmaceuticals (ANIP) | 0.8 | $12M | 143k | 82.20 | |
Krystal Biotech (KRYS) | 0.5 | $7.3M | 182k | 40.27 | |
Savara (SVRA) | 0.3 | $3.7M | 1.6M | 2.37 | |
Immunomedics | 0.1 | $2.0M | 145k | 13.87 | |
ArQule | 0.0 | $551k | 50k | 11.02 | |
Homology Medicines | 0.0 | $512k | 26k | 19.57 |